Blueprint Medicines Corporation (BPMC) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Blueprint Medicines Corporation, with annual and quarterly history.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -81.72x | -11.02x | -4.69x | -9.73x | 19.48x | -11.66x |
| P/B Ratio | 18.36x | 42.77x | 5.08x | 6.46x | 4.16x | 8.25x |
| P/S Ratio | 10.77x | 22.40x | 12.81x | 34.81x | 7.71x | 57.61x |
| Profitability | ||||||
| Gross Margin | 96.0% | 94.9% | 91.3% | 90.0% | 99.9% | 100.0% |
| Operating Margin | -41.7% | -195.0% | -269.2% | -360.1% | 38.1% | -551.2% |
| Net Margin | -13.2% | -203.3% | -273.2% | -357.7% | 39.5% | -494.2% |
| EBITDA Margin | 3.8% | -188.6% | -252.6% | -348.9% | 38.9% | -535.3% |
| Liquidity | ||||||
| Current Ratio | 2.85x | 3.76x | 5.71x | 3.70x | 7.09x | 4.85x |
| Quick Ratio | 2.80x | 3.66x | 5.55x | 3.55x | 7.03x | 8.93x |
| Leverage | ||||||
| Debt/Equity | 1.57x | 5.93x | 0.47x | 0.11x | 0.06x | 0.21x |
YoY = year-over-year change. Source: FMP..